Vault-13

DAFNA Capital Management LLC

LOS ANGELES, CA · CIK 1389933 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2003 · limited liability company

As an employer

$524.4m reported value +19.3% vs Q1 2026
88positions
56.2%in top 10
17 new 17 added 26 reduced 12 sold out vs Q1 2026

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 562,630 $105.4m20.09% 20.09% ReducedShares held: Q3 2025 657.2k, Q4 2025 604.5k, Q1 2026 580.7k, Q2 2026 562.6k -18.0k -18,048 -3.1%
2 SPDR SER TR S&P BIOTECH XBI XBI 196,505 $31.1m5.93% 5.93% ReducedShares held: Q3 2025 401.5k, Q4 2025 336.5k, Q1 2026 318.5k, Q2 2026 196.5k -122.0k -122,000 -38.3%
3 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 2,011,952 $28.5m5.43% 5.43% ReducedShares held: Q3 2025 811.0k, Q4 2025 811.0k, Q1 2026 2.4m, Q2 2026 2.0m -406.9k -406,930 -16.8%
4 STEREOTAXIS INC COM NEW STXS STXS 13,680,554 $23.5m4.49% 4.49% UnchangedShares held: Q3 2025 13.7m, Q4 2025 13.7m, Q1 2026 13.7m, Q2 2026 13.7m
5 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 318,380 $22.2m4.24% 4.24% AddedShares held: Q3 2025 55.0k, Q4 2025 75.0k, Q1 2026 165.2k, Q2 2026 318.4k +153.2k +153,202 92.8%
6 DENALI THERAPEUTICS INC COM DNLI DNLI 739,014 $19.0m3.62% 3.62% AddedShares held: Q3 2025 168.5k, Q4 2025 318.5k, Q1 2026 318.5k, Q2 2026 739.0k +420.5k +420,514 132.0%
7 IDEAYA BIOSCIENCES INC COM IDYA IDYA 497,240 $18.5m3.53% 3.53% AddedShares held: Q3 2025 539.9k, Q4 2025 506.7k, Q1 2026 476.7k, Q2 2026 497.2k +20.5k +20,500 4.3%
8 ATRICURE INC COM ATRC ATRC 597,431 $16.7m3.19% 3.19% UnchangedShares held: Q3 2025 592.3k, Q4 2025 597.4k, Q1 2026 597.4k, Q2 2026 597.4k
9 XENON PHARMACEUTICALS INC COM XENE XENE 250,772 $15.1m2.89% 2.89% UnchangedShares held: Q3 2025 287.9k, Q4 2025 287.9k, Q1 2026 250.8k, Q2 2026 250.8k
10 CYTOKINETICS INC COM NEW CYTK CYTK 171,998 $14.7m2.79% 2.79% ReducedShares held: Q3 2025 394.9k, Q4 2025 371.0k, Q1 2026 217.5k, Q2 2026 172.0k -45.5k -45,499 -20.9%
11 ARCUS BIOSCIENCES INC COM RCUS RCUS 441,829 $13.6m2.60% 2.60% ReducedShares held: Q3 2025 627.6k, Q4 2025 431.3k, Q1 2026 443.8k, Q2 2026 441.8k -2.0k -2,000 -0.5%
12 ASCENDIS PHARMA A/S ORD SHS ASND ASND 48,469 $12.9m2.47% 2.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 48.5k
13 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 57,769 $9.7m1.86% 1.86% ReducedShares held: Q3 2025 70.6k, Q4 2025 70.6k, Q1 2026 70.6k, Q2 2026 57.8k -12.8k -12,846 -18.2%
14 AXOGEN INC COM AXGN AXGN 208,960 $9.7m1.84% 1.84% ReducedShares held: Q3 2025 742.3k, Q4 2025 476.8k, Q1 2026 250.0k, Q2 2026 209.0k -41.0k -41,000 -16.4%
15 INSULET CORP COM PODD PODD 61,870 $9.4m1.80% 1.80% AddedShares held: Q3 2025 6.9k, Q4 2025 6.9k, Q1 2026 10.9k, Q2 2026 61.9k +51.0k +51,000 469.2%
16 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 226,819 $9.2m1.76% 1.76% AddedShares held: Q3 2025 213.7k, Q4 2025 159.7k, Q1 2026 112.2k, Q2 2026 226.8k +114.6k +114,583 102.1%
17 BICARA THERAPEUTICS INC COM BCAX BCAX 284,955 $8.5m1.61% 1.61% ReducedShares held: Q3 2025 317.0k, Q4 2025 261.6k, Q1 2026 421.7k, Q2 2026 285.0k -136.8k -136,778 -32.4%
18 ISHARES TR ISHARES BIOTECH IBB IBB 42,595 $8.1m1.54% 1.54% ReducedShares held: Q3 2025 102.5k, Q4 2025 68.1k, Q1 2026 62.1k, Q2 2026 42.6k -19.5k -19,500 -31.4%
19 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 335,255 $7.3m1.40% 1.40% AddedShares held: Q3 2025 500.7k, Q4 2025 277.9k, Q1 2026 217.4k, Q2 2026 335.3k +117.9k +117,900 54.2%
20 MAPLIGHT THERAPEUTICS INC COM MPLT MPLT 171,006 $6.1m1.17% 1.17% UnchangedShares held: Q3 2025 0, Q4 2025 143.8k, Q1 2026 171.0k, Q2 2026 171.0k
21 LARIMAR THERAPEUTICS INC COM LRMR LRMR 2,008,164 $6.1m1.17% 1.17% ReducedShares held: Q3 2025 1.0m, Q4 2025 939.2k, Q1 2026 2.0m, Q2 2026 2.0m -21.0k -21,000 -1.0%
22 CENTURY THERAPEUTICS INC COM IPSC IPSC 2,400,458 $5.9m1.12% 1.12% ReducedShares held: Q3 2025 1.7m, Q4 2025 2.8m, Q1 2026 2.4m, Q2 2026 2.4m -33.9k -33,895 -1.4%
23 DEXCOM INC COM DXCM DXCM 86,279 $5.8m1.11% 1.11% UnchangedShares held: Q3 2025 65.6k, Q4 2025 88.3k, Q1 2026 86.3k, Q2 2026 86.3k
24 IMMUNOVANT INC COM IMVT IMVT 149,524 $5.8m1.10% 1.10% ReducedShares held: Q3 2025 191.5k, Q4 2025 150.5k, Q1 2026 150.5k, Q2 2026 149.5k -1.0k -1,000 -0.7%
25 INOGEN INC COM INGN INGN 845,179 $5.5m1.04% 1.04% UnchangedShares held: Q3 2025 605.6k, Q4 2025 827.1k, Q1 2026 845.2k, Q2 2026 845.2k
26 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 355,208 $5.4m1.02% 1.02% UnchangedShares held: Q3 2025 355.2k, Q4 2025 355.2k, Q1 2026 355.2k, Q2 2026 355.2k
27 ALKERMES PLC SHS ALKS ALKS 101,266 $5.3m1.01% 1.01% ReducedShares held: Q3 2025 134.7k, Q4 2025 130.2k, Q1 2026 139.5k, Q2 2026 101.3k -38.2k -38,216 -27.4%
28 STOKE THERAPEUTICS INC COM STOK STOK 130,875 $4.3m0.82% 0.82% UnchangedShares held: Q3 2025 169.8k, Q4 2025 108.9k, Q1 2026 130.9k, Q2 2026 130.9k
29 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 2,000,000 $4.2m0.79% 0.79% AddedShares held: Q3 2025 1.4m, Q4 2025 1.4m, Q1 2026 1.4m, Q2 2026 2.0m +629.9k +629,882 46.0%
30 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 400,248 $4.0m0.76% 0.76% ReducedShares held: Q3 2025 218.3k, Q4 2025 418.3k, Q1 2026 430.2k, Q2 2026 400.2k -30.0k -30,000 -7.0%
31 GALAPAGOS NV SPON ADR LKFT LKFT 130,175 $3.9m0.74% 0.74% UnchangedShares held: Q3 2025 130.2k, Q4 2025 130.2k, Q1 2026 130.2k, Q2 2026 130.2k
32 ORTHOPEDIATRICS CORP COM KIDS KIDS 189,130 $3.6m0.69% 0.69% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 95.7k, Q2 2026 189.1k +93.5k +93,471 97.7%
33 CYBIN INC COM NEW COM NEW 514,061 $3.4m0.65% 0.65% AddedShares held: Q3 2025 0, Q4 2025 455.0k, Q1 2026 498.4k, Q2 2026 514.1k +15.7k +15,700 3.1%
34 RAPPORT THERAPEUTICS INC COM RAPP RAPP 75,000 $3.1m0.60% 0.60% UnchangedShares held: Q3 2025 75.0k, Q4 2025 75.0k, Q1 2026 75.0k, Q2 2026 75.0k
35 KYMERA THERAPEUTICS INC COM KYMR KYMR 27,000 $3.1m0.59% 0.59% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 27.0k
36 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 1,530,361 $2.8m0.54% 0.54% ReducedShares held: Q3 2025 1.6m, Q4 2025 1.6m, Q1 2026 1.6m, Q2 2026 1.5m -37.2k -37,200 -2.4%
37 NEUROGENE INC COM NGNE NGNE 89,032 $2.8m0.53% 0.53% AddedShares held: Q3 2025 30.4k, Q4 2025 28.0k, Q1 2026 56.6k, Q2 2026 89.0k +32.4k +32,397 57.2%
38 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 239,553 $2.8m0.53% 0.53% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 239.6k
39 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 120,000 $2.7m0.52% 0.52% UnchangedShares held: Q3 2025 0, Q4 2025 120.0k, Q1 2026 120.0k, Q2 2026 120.0k
40 AQUESTIVE THERAPEUTICS INC COM AQST AQST 645,915 $2.7m0.51% 0.51% AddedShares held: Q3 2025 512.6k, Q4 2025 375.9k, Q1 2026 368.4k, Q2 2026 645.9k +277.5k +277,500 75.3%
41 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 68,518 $2.5m0.49% 0.49% UnchangedShares held: Q3 2025 24.5k, Q4 2025 68.5k, Q1 2026 68.5k, Q2 2026 68.5k
42 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 46,500 $2.5m0.48% 0.48% UnchangedShares held: Q3 2025 59.0k, Q4 2025 37.0k, Q1 2026 46.5k, Q2 2026 46.5k
43 ALIGN TECHNOLOGY INC COM ALGN ALGN 14,000 $2.4m0.45% 0.45% ReducedShares held: Q3 2025 11.0k, Q4 2025 16.0k, Q1 2026 15.0k, Q2 2026 14.0k -1.0k -1,000 -6.7%
44 VIKING THERAPEUTICS INC COM VKTX VKTX 59,516 $2.3m0.44% 0.44% UnchangedShares held: Q3 2025 64.5k, Q4 2025 59.5k, Q1 2026 59.5k, Q2 2026 59.5k
45 NERVGEN PHARMA CORP COM NGEN NGEN 1,050,000 $2.2m0.41% 0.41% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
46 BIOHAVEN LTD COM BHVN BHVN 137,593 $2.0m0.39% 0.39% ReducedShares held: Q3 2025 235.2k, Q4 2025 955.2k, Q1 2026 845.7k, Q2 2026 137.6k -708.1k -708,142 -83.7%
47 MAZE THERAPEUTICS INC COM MAZE MAZE 65,000 $1.9m0.37% 0.37% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 35.0k, Q2 2026 65.0k +30.0k +30,000 85.7%
48 ALECTOR INC COM ALEC ALEC 908,351 $1.8m0.35% 0.35% UnchangedShares held: Q3 2025 798.4k, Q4 2025 908.4k, Q1 2026 908.4k, Q2 2026 908.4k
49 LEXEO THERAPEUTICS INC COM LXEO LXEO 377,059 $1.8m0.33% 0.33% UnchangedShares held: Q3 2025 358.1k, Q4 2025 340.9k, Q1 2026 377.1k, Q2 2026 377.1k
50 PROFOUND MED CORP COM NEW PROF PROF 260,360 $1.7m0.33% 0.33% ReducedShares held: Q3 2025 0, Q4 2025 285.7k, Q1 2026 263.0k, Q2 2026 260.4k -2.6k -2,645 -1.0%
51 ATRIUM THERAPEUTICS INC COM RNA RNA 128,000 $1.7m0.33% 0.33% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 128.0k
52 ANNEXON INC COM ANNX ANNX 297,812 $1.7m0.32% 0.32% AddedShares held: Q3 2025 0, Q4 2025 272.8k, Q1 2026 117.8k, Q2 2026 297.8k +180.0k +180,000 152.8%
53 CYTOMX THERAPEUTICS INC COM CTMX CTMX 438,407 $1.6m0.31% 0.31% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 230.0k, Q2 2026 438.4k +208.4k +208,407 90.6%
54 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 47,100 $1.6m0.30% 0.30% ReducedShares held: Q3 2025 0, Q4 2025 16.0k, Q1 2026 61.1k, Q2 2026 47.1k -14.0k -14,000 -22.9%
55 EUPRAXIA PHARMACEUTICALS INC COM EPRX EPRX 225,600 $1.5m0.28% 0.28% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 225.6k
56 DESIGN THERAPEUTICS INC COM DSGN DSGN 102,600 $1.5m0.28% 0.28% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 102.6k
57 FATE THERAPEUTICS INC COM FATE FATE 525,000 $1.4m0.27% 0.27% ReducedShares held: Q3 2025 0, Q4 2025 550.0k, Q1 2026 550.0k, Q2 2026 525.0k -25.0k -25,000 -4.5%
58 MEDIWOUND LTD SHS NEW MDWD MDWD 94,405 $1.4m0.26% 0.26% UnchangedShares held: Q3 2025 113.6k, Q4 2025 113.6k, Q1 2026 94.4k, Q2 2026 94.4k
59 KURA ONCOLOGY INC COM KURA KURA 120,568 $1.3m0.25% 0.25% ReducedShares held: Q3 2025 463.4k, Q4 2025 235.9k, Q1 2026 235.9k, Q2 2026 120.6k -115.3k -115,300 -48.9%
60 ARS PHARMACEUTICALS INC COM SPRY SPRY 164,285 $1.3m0.25% 0.25% AddedShares held: Q3 2025 140.5k, Q4 2025 190.1k, Q1 2026 139.3k, Q2 2026 164.3k +25.0k +25,000 17.9%
61 MINERALYS THERAPEUTICS INC COM MLYS MLYS 44,490 $1.2m0.23% 0.23% AddedShares held: Q3 2025 83.5k, Q4 2025 38.5k, Q1 2026 38.5k, Q2 2026 44.5k +6.0k +6,000 15.6%
62 IMMATICS N.V SHS IMTX IMTX 116,960 $1.2m0.23% 0.23% ReducedShares held: Q3 2025 235.0k, Q4 2025 261.1k, Q1 2026 225.9k, Q2 2026 117.0k -108.9k -108,900 -48.2%
63 TELA BIO INC COM TELA TELA 1,441,029 $1.1m0.21% 0.21% UnchangedShares held: Q3 2025 1.4m, Q4 2025 1.4m, Q1 2026 1.4m, Q2 2026 1.4m
64 POLYPID LTD COM PYPD PYPD 207,900 $1.1m0.20% 0.20% UnchangedShares held: Q3 2025 207.9k, Q4 2025 207.9k, Q1 2026 207.9k, Q2 2026 207.9k
65 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 107,773 $1.0m0.19% 0.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 107.8k
66 INSPIRE MED SYS INC COM INSP INSP 18,200 $811.9k0.15% 0.15% UnchangedShares held: Q3 2025 17.2k, Q4 2025 8.6k, Q1 2026 18.2k, Q2 2026 18.2k
67 ADICET BIO INC COM NEW ACET ACET 93,812 $810.5k0.15% 0.15% UnchangedShares held: Q3 2025 0, Q4 2025 93.8k, Q1 2026 93.8k, Q2 2026 93.8k
68 SEAPORT THERAPEUTICS INC COMMON STOCK SPTX SPTX 32,400 $703.7k0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 32.4k
69 MBX BIOSCIENCES INC COM MBX MBX 11,809 $651.9k0.12% 0.12% ReducedShares held: Q3 2025 85.0k, Q4 2025 165.3k, Q1 2026 175.5k, Q2 2026 11.8k -163.7k -163,656 -93.3%
70 BIONTECH SE SPONSORED ADS BNTX BNTX 7,000 $651.4k0.12% 0.12% UnchangedShares held: Q3 2025 7.0k, Q4 2025 7.0k, Q1 2026 7.0k, Q2 2026 7.0k
71 ARTIVA BIOTHERAPEUTICS INC COM ARTV ARTV 67,101 $650.9k0.12% 0.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 67.1k
72 PLIANT THERAPEUTICS INC COM PLRX PLRX 487,000 $555.2k0.11% 0.11% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 487.0k, Q2 2026 487.0k
73 SCYNEXIS INC COM SCYX SCYX 135,868 $553.0k0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 135.9k
74 EDITAS MEDICINE INC COM EDIT EDIT 170,470 $552.3k0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 170.5k
75 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 126,841 $547.3k0.10% 0.10% UnchangedShares held: Q3 2025 363.6k, Q4 2025 126.8k, Q1 2026 126.8k, Q2 2026 126.8k
76 FOGHORN THERAPEUTICS INC COM FHTX FHTX 111,859 $545.9k0.10% 0.10% UnchangedShares held: Q3 2025 126.9k, Q4 2025 126.9k, Q1 2026 111.9k, Q2 2026 111.9k
77 ACCURAY INC COM ARAY ARAY 1,680,508 $433.2k0.08% 0.08% UnchangedShares held: Q3 2025 1.2m, Q4 2025 1.4m, Q1 2026 1.7m, Q2 2026 1.7m
78 Q32 BIO INC COM QTTB QTTB 32,896 $419.1k0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 32.9k
79 NUVECTIS PHARMA INC COM NVCT NVCT 20,000 $367.8k0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 20.0k
80 COMPUGEN LTD ORD CGEN CGEN 168,232 $360.0k0.07% 0.07% ReducedShares held: Q3 2025 272.4k, Q4 2025 272.4k, Q1 2026 257.8k, Q2 2026 168.2k -89.6k -89,551 -34.7%
81 IBIO INC COM NEW IBIO IBIO 170,053 $297.6k0.06% 0.06% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 193.6k, Q2 2026 170.1k -23.6k -23,585 -12.2%
82 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 179,316 $286.9k0.05% 0.05% UnchangedShares held: Q3 2025 179.3k, Q4 2025 179.3k, Q1 2026 179.3k, Q2 2026 179.3k
83 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 64,492 $273.4k0.05% 0.05% UnchangedShares held: Q3 2025 64.5k, Q4 2025 64.5k, Q1 2026 64.5k, Q2 2026 64.5k
84 TENAYA THERAPEUTICS INC COM TNYA TNYA 300,000 $221.7k0.04% 0.04% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 300.0k
85 VERRICA PHARMACEUTICALS INC COM SHS VRCA VRCA 23,750 $145.3k0.03% 0.03% ReducedShares held: Q3 2025 0, Q4 2025 173.5k, Q1 2026 153.7k, Q2 2026 23.8k -130.0k -129,962 -84.5%
86 ENGENE THERAPEUTICS INC COM ENGN ENGN 74,650 $129.1k0.02% 0.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 74.7k
87 KARDIGAN INC COM KARD KARD 5,000 $119.2k0.02% 0.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.0k
88 ADC THERAPEUTICS SA SHS ADCT ADCT 77,081 $82.5k0.02% 0.02% AddedShares held: Q3 2025 122.1k, Q4 2025 77.1k, Q1 2026 72.1k, Q2 2026 77.1k +5.0k +5,000 6.9%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
DAY ONE BIOPHARMACEUTICALS I 978,463 $21.0m978.5k shares
ASCENDIS PHARMA A/S ASND 2.25 04.01.28 ASND 2.25 04.01.28 4,000,000 $5.9m4.0m shares
KALVISTA PHARMACEUTICALS INC KALV KALV 267,402 $5.4m267.4k shares
ASCENDIS PHARMA A/S 23,177 $5.3m23.2k shares
FULCRUM THERAPEUTICS INC FULC FULC 205,000 $1.6m205.0k shares
ENGENE HOLDINGS INC 187,353 $1.3m187.4k shares
SCYNEXIS INC 1,086,956 $996.6k1.1m shares
ORIC PHARMACEUTICALS INC ORIC ORIC 98,724 $945.5k98.7k shares
ZENAS BIOPHARMA INC ZBIO ZBIO 42,500 $830.9k42.5k shares
NEWAMSTERDAM PHARMA COMPANY NAMS NAMS 20,000 $640.2k20.0k shares
KARYOPHARM THERAPEUTICS INC KPTI KPTI 45,800 $255.1k45.8k shares
NEUMORA THERAPEUTICS INC. NMRA NMRA 70,000 $136.5k70.0k shares